Evidence map›Paper›PMID 29636422›Full record

ArticleStroke2018

Beneficial Role of Neutrophils Through Function of Lactoferrin After Intracerebral Hemorrhage.

Xiurong Zhao, Shun-Ming Ting, Guanghua Sun, Meaghan Roy-O'Reilly, Alexis S Mobley, Jesus Bautista Garrido, Xueping Zheng, Lidiya Obertas, Joo Eun Jung, Marian Kruzel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Stroke, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Role of Neutrophils as Therapeutic Targets in Intracerebral Hemorrhage.Therapeutic innovation & regulatory science · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Xiurong ZhaoFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Shun-Ming TingFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Guanghua SunFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Meaghan Roy-O'ReillyFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Alexis S MobleyFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Jesus Bautista GarridoFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Xueping ZhengFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Lidiya ObertasFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Joo Eun JungFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.).
Marian KruzelDepartment of Integrative Biology and Pharmacology (M.K.), McGovern Medical School, University of Texas HSC, Houston.
Jaroslaw AronowskiFrom the Department of Neurology (X.Z., S.-M.T., G.S., M.R.-O., A.S.M., J.B.G., X.Z., L.O., J.E.J., J.A.) j.aronowski@uth.tmc.edu.
The University of Texas Health Science Center · US

Funding

Neutrophils in Recovery after ICHR01NS096308 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARONOWSKI, JAROSLAW · 2016 to 2020
$1.8M
Optimized lactoferrin for treatment of intracerebral hemorrhageR42NS090650 · NINDS · PHARMAREVIEW CORPORATION · PI ARONOWSKI, JAROSLAW, KRUZEL, MARIAN L · 2016 to 2017
$1.6M
Optimized lactoferrin for treatment of intracerebral hemorrhageR41NS090650 · NINDS · PHARMAREVIEW CORPORATION · PI ARONOWSKI, JAROSLAW, KRUZEL, MARIAN L · 2014 to 2015
$237k
Treatment of Ischemic Stroke in Aged Populations: Sex-Specific Targeting of the Neutrophil ResponseF30NS098628 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ROY-O'REILLY, MEAGHAN A. · 2017 to 2019
$108k
NINDS NIH HHS F30 NS098628NINDS NIH HHS R01 NS096308NINDS NIH HHS R41 NS090650NINDS NIH HHS R42 NS090650
6 · The paper itself

Abstract

background and purposeIntracerebral hemorrhage (ICH) is a devastating disease with a 30-day mortality of ~50%. There are no effective therapies for ICH. ICH results in brain damage in 2 major ways: through the mechanical forces of extravasated blood and then through toxicity of the intraparenchymal blood components including hemoglobin/iron. LTF (lactoferrin) is an iron-binding protein, uniquely abundant in polymorphonuclear neutrophils (PMNs). After ICH, circulating blood PMNs enter the ICH-afflicted brain where they release LTF. By virtue of sequestrating iron, LTF may contribute to hematoma detoxification.

methodsICH in mice was produced using intrastriatal autologous blood injection. PMNs were depleted with intraperitoneal administration of anti-Ly-6G antibody. Treatment of mouse brain cell cultures with lysed RBC or iron was used as in vitro model of ICH.

resultsLTF mRNA was undetectable in the mouse brain, even after ICH. Unlike mRNA, LTF protein increased in ICH-affected hemispheres by 6 hours, peaked at 24 to 72 hours, and remained elevated for at least a week after ICH. At the single cell level, LTF was detected in PMNs in the hematoma-affected brain at all time points after ICH. We also found elevated LTF in the plasma after ICH, with a temporal profile similar to LTF changes in the brain. Importantly, mrLTF (recombinant mouse LTF) reduced the cytotoxicity of lysed RBC and FeCl

conclusionsLTF delivered to the ICH-affected brain by infiltrating PMNs may assist in hematoma detoxification and represent a powerful potential target for the treatment of ICH.

Indexed as

AnimalsBrainBrain EdemaCell Culture TechniquesCerebral HemorrhageDisease Models, AnimalErythrocytesHematomaIn Vitro TechniquesIronLactoferrinMiceNeutrophilsRNA, MessengerIronLactoferrinRNA, Messengerbrain edemainflammationlactoferrinneutrophiltransferrin

Identifiers

PMID29636422
PMCPMC5915919
OpenAlexW2798178980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.